Skip to content

FEMY

Femasys Inc.

NASDAQ · Healthcare · Medical - Instruments & Supplies · US

$2.98
−2.61%
Ask drillr
5
Insider buys (3m)
0
Insider sells (3m)
$134.0K
Net value (3m)
-51.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 11, 2026Milnes Alistair · directorA-Award880$3.67
Aug 11, 2026Uzialko Edward R · directorA-Award880$3.67
Aug 11, 2026Eichenbaum Kenneth D. · directorA-Award880$3.67
Aug 11, 2026Lee-Sepsick Kathy · director, officer: Chief Executive OfficerA-Award15,625$2.95
Aug 11, 2026Lee-Sepsick Kathy · director, officer: Chief Executive OfficerPurchase15,625$3.20
Aug 11, 2026Elefant Dov · officer: Chief Financial OfficerA-Award15,625$2.95
Aug 11, 2026Elefant Dov · officer: Chief Financial OfficerPurchase15,625$3.20
Aug 11, 2026Canning John Charles · officer: Chief Operating OfficerA-Award4,375$2.95
Aug 11, 2026Canning John Charles · officer: Chief Operating OfficerPurchase4,375$3.20
Aug 11, 2026Sipos Jeremy Alexander · officer: Chief Technology OfficerA-Award3,125$2.95
Aug 11, 2026Sipos Jeremy Alexander · officer: Chief Technology OfficerPurchase3,125$3.20
Aug 11, 2026Mifek Jeffrey Gerald · officer: Chief Clinical-Medical AffairsA-Award6,250$4.08
Aug 11, 2026Mifek Jeffrey Gerald · officer: Chief Clinical-Medical AffairsA-Award3,125$2.95
Aug 11, 2026Mifek Jeffrey Gerald · officer: Chief Clinical-Medical AffairsPurchase3,125$3.20
Aug 11, 2026Larsen Charles · directorA-Award880$3.67
Apr 1, 2026Canning John Charles · officer: Chief Operating OfficerA-Award150,000$0.38
Mar 27, 2026Larsen Charles · directorA-Award34,122$0.58
Mar 27, 2026Elefant Dov · officer: Chief Financial OfficerA-Award34,122$0.58
Mar 27, 2026Lee-Sepsick Kathy · director, officer: Chief Executive OfficerA-Award68,244$0.58
Mar 27, 2026Eichenbaum Kenneth D. · directorA-Award102,366$0.58
Mar 20, 2026Eichenbaum Kenneth D. · directorA-Award35,200$0.60
Feb 20, 2026Lee-Sepsick Kathy · director, officer: Chief Executive OfficerA-Award447,000$0.00
Feb 20, 2026Elefant Dov · officer: Chief Financial OfficerA-Award169,000$0.00
Feb 20, 2026Elefant Dov · officer: Chief Financial OfficerA-Award173,000$0.00
Feb 20, 2026Lee-Sepsick Kathy · director, officer: Chief Executive OfficerA-Award282,000$0.00
Feb 17, 2026Sipos Jeremy Alexander · officer: Chief Technology OfficerA-Award80,000$0.00
Jul 1, 2025Nicholas Kelley Stinson · officer: Chief Commercial OfficerA-Award100,000$0.90
Jun 27, 2025Larsen Charles · directorA-Award17,600$0.98
Jun 27, 2025Uzialko Edward R · directorA-Award17,600$0.98
Jun 27, 2025Milnes Alistair · directorA-Award17,600$0.98
Institutional positioning

13F filings over the trailing two quarters

New 9Increased 7Reduced 9Sold out 33
FilerActionSharesFiled
DAUNTLESS INVESTMENT GROUP, LLCIncreased6,033,030May 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1,236,673May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased621,366May 15, 2026
VANGUARD FIDUCIARY TRUST CONew Position249,876May 15, 2026
BLACKROCK, INC.Increased178,501May 13, 2026
NORTHERN TRUST CORPIncreased118,411May 14, 2026
CLEAR CREEK FINANCIAL MANAGEMENT, LLCIncreased115,556Apr 23, 2026
EP WEALTH ADVISORS, LLCNew Position100,000May 14, 2026
XTX TOPCO LTDIncreased94,142May 15, 2026
STATE STREET CORPUnchanged80,869May 15, 2026
VIRTU FINANCIAL LLCNew Position80,150May 14, 2026
KOVACK ADVISORS, INC.Reduced70,000May 13, 2026
CETERA INVESTMENT ADVISERSUnchanged62,000May 13, 2026
UBS GROUP AGReduced61,929May 5, 2026
ADVISOR GROUP HOLDINGS, INC.Increased47,964May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 11, 2026